Insider Selling: Privia Health Group (NASDAQ:PRVA) CFO Sells $588,679.25 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 21,275 shares of the stock in a transaction on Thursday, July 9th. The shares were sold at an average price of $27.67, for a total value of $588,679.25. Following the completion of the transaction, the chief financial officer directly owned 164,853 shares in the company, valued at approximately $4,561,482.51. This trade represents a 11.43% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Tuesday, July 7th, David Mountcastle sold 600 shares of Privia Health Group stock. The stock was sold at an average price of $27.57, for a total value of $16,542.00.
• On Thursday, July 2nd, David Mountcastle sold 24,734 shares of Privia Health Group stock. The shares were sold at an average price of $27.50, for a total value of $680,185.00.
• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The shares were sold at an average price of $25.18, for a total value of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The shares were sold at an average price of $22.60, for a total value of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total value of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total value of $179,690.37.

Privia Health Group Trading Up 0.2%

Privia Health Group stock opened at $28.10 on Thursday. The firm has a market capitalization of $3.54 billion, a P/E ratio of 175.64, a PEG ratio of 2.22 and a beta of 0.83. The business has a 50-day moving average of $23.98 and a 200-day moving average of $23.22. Privia Health Group, Inc. has a 1 year low of $18.77 and a 1 year high of $28.41.

Analyst Ratings Changes

PRVA has been the subject of several recent analyst reports. Zacks Research downgraded shares of Privia Health Group from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 7th. Canaccord Genuity Group decreased their price target on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a report on Friday, May 8th. Barclays lowered their price objective on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Evercore set a $26.00 price objective on Privia Health Group in a research note on Wednesday, April 8th. Finally, Weiss Ratings upgraded Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 2nd. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus price target of $31.15.

Institutional Investors Weigh In On Privia Health Group

Several large investors have recently made changes to their positions in the stock. Bayban bought a new stake in Privia Health Group in the 4th quarter valued at $26,000. Hantz Financial Services Inc. raised its stake in shares of Privia Health Group by 456.2% in the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after purchasing an additional 926 shares during the period. Global Retirement Partners LLC raised its stake in shares of Privia Health Group by 579.8% in the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after purchasing an additional 1,351 shares during the period. Harbor Investment Advisory LLC bought a new stake in shares of Privia Health Group in the second quarter valued at about $69,000. Finally, Canada Pension Plan Investment Board lifted its holdings in shares of Privia Health Group by 48.0% in the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.